Regularly reviewing a patient's medication list should not be overlooked as a routine task; it is a vital step in ensuring patient safety and effective diabetes management. While the FDA is investigating the possible link between acute pancreatitis and SGLT-2 inhibitors, clinicians should be aware of this interrelation to enhance the management of their diabetic patients. The gene discussed is SLC5A2; the disease is acute pancreatitis.